Use of a bovine jugular vein graft with natural valve for right ventricular outflow tract reconstruction: A one-year animal study  by Ichikawa, Yukio et al.
USE OF A BOVINE JUGULAR VEIN GRAFT WITH NATURAL VALVE FOR RIGHT VENTRICULAR 
OUTFLOW TRACT RECONSTRUCTION: A ONE-YEAR ANIMAL STUDY 
Yukio Ichikawa, MD, PhD 
Yasuharu Noishiki, MD, PhD 
Takayuki Kosuge, MD, PhD 
Kenji Yamamoto, MD, PhD 
Jiro Kondo, MD, PhD 
Akihiko Matsumoto, MD, PhD 
Objective: We evaluated a bovine jugular vein graft with a natural trileaflet 
valve for right ventricular outflow tract reconstruction in a canine study for 
an entire year. Methods: Heparinized bovine jugular vein grafts with a 
natural valve cross-linked with a hydrophilic polyepoxy compound of 18 to 
20 mm in internal diameter were implanted in the right ventricular- 
pulmonary arterial position in eight dogs, and the main natural pulmonary 
artery was ligated. Anticoagulants were not used after implantation. Five 
grafts were retrieved on day 182 after implantation and the other three 
grafts on days 196, 375, and 385, respectively, and were inspected by 
macroscopic and microscopic observation. Cardiac catheterization, fol- 
lowed by angiography and echocardiography, was done just before graft 
retrieval. Results: No graft kinking or regurgitation of the valve was 
observed. Echocardiography showed natural valve motion without thicken- 
ing of the leaflets. Blood pressure in the conduits ranged from 18/9 to 31/4 
mm Hg, in the right ventricle from 18/4 to 40/0 mm Hg, and the gradient 
varied from 0 to 14 mm Hg. The explanted conduits maintained their 
original shape, softness, and pliability with good coaptation of valves, 
without calcification or degenerative changes, except for one leaflet with 
slight deformation. In microscopic observation, endothelial ceils lined the 
luminal surface of the conduit except for the areas adjacent to the valve. 
Conclusion: The graft worked perfectly as a right ventricular-pulmonary 
arterial valved conduit without anticoagulant herapy for a long time. 
(J Thorac Cardiovasc Surg 1997;114:224-33) 
M any kinds of extracardiac conduits have been developed, but the valves of these conduits do 
not maintain satisfactory hemodynamic function in 
the low-pressure pulmonary arterial system for very 
long after implantation. The major problems are the 
inadequacy of synthetic valves, stenosis caused by 
degenerative changes of the biologic conduits, or 
peeling of the pseudointima on the grafts, lq3 Other 
limitations are size, availability, and antithromboge- 
nicity of such bioprostheses for children. Many 
other problems are present as well, such as the 
quality of the raw materials and cross-linking of the 
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bioprostheses in clinics. The ideal graft has to have 
ideal structure and hemodynamic properties. The 
cross-linking must provide biocompatibility and hy- 
drophilic properties without cytotoxicity. We must 
also be able to obtain various sizes of conduits 
readily at any time. To solve these problems, we 
developed a conduit using bovine jugular veins, 
which contain a natural trileaflet valve. These veins 
with natural valves have the structure peculiar to 
venous tissue, which makes them adequate to func- 
tion as a valved conduit in the low-pressure system. 
To preserve the mechanical properties of the natu- 
ral tissues and to reduce the immunogenicity of the 
animal tissue, we treated the graft with a hydrophilic 
polyepoxy compound (PC) instead of the usual 
glutaraldehyde. Studies have been conducted com- 
paring the mechanical properties of biologic pros- 
theses cross-linked with PC or glutaraldehyde by 
measuring their compliance and pliability. An arte- 
rial vascular prosthesis cross-linked with PC showed 
more pliability than one cross-linked with glutaral- 
dehyde? 4 The porcine valvular leaflets cross-linked 
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with PC were more pliable than their glutaraldehyde 
counterparts in two-dimensional echocardiographic 
inspection. Epoxy-treated valves appeared to open 
more widely than glutaraldehyde-treated valves. 
Also, less calcium deposition and pannus ingrowth 
were observed in the epoxy compound valve than in 
its glutaraldehyde counterpart. 15
For antithrombogenicity, heparin was immobi- 
lized with protamine sulfate on the luminal surface 
of the graft. In this communication, we report the 
1-year esults with such a graft in a canine study. The 
results show that the new right ventricular-pulmo- 
nary arterial conduit with a valve naturally function- 
ing in a low-pressure system provides satisfactory 
hemodynamics and excellent preservation of the 
venous characteristics. 
Materials and methods 
Preparation of the conduit. A fresh bovine jugular vein 
with a natural valve of 18 to 20 mm in internal diameter 
was obtained from a slaughterhouse. It was soaked in 
distilled water for 1 hour and sonieated at 28 kc for 20 
seconds to cause cell destruction. Cell debris and water- 
soluble proteins were removed by squeezing the vein in 
distilled water. Thus a natural tissue tube composed of 
collagen and elastic laminae was obtained (Fig. 1). A 0.7% 
protamine sulfate solution, pH 5.9, was impregnated into 
the luminal surface of the tube by air inflation at a 
pressure Of 30 mm Hg. During the impregnation, the tube 
was crimped and cross-linked in a 4% solution of glycerol 
polyglyeidyl ether polyepoxy compound (PC, Denacol 
EX-313; Nagase Chemical, Osaka, Japan), pH 9.5 -+ 0.2 
(0,2 mol/L carbonate-bicarbonate buffer), for 45 + 3 
hours at 37 ° C. After being rinsed with distilled water for 
more than 24 hours, the tube was soaked in a 1% heparin 
solution at pH 4.5 for 5 hours at 45 ° C and then washed 
again with distilled water for 24 hours. Then it was 
sterilized in a 4% solution of PC (Denacol Ex-810; 
Nagase) for 6 days at 38 ° C and preserved in 70% ethanol. 
Before implantation, the graft wassqueezed with a dry 
sponge and immersed in physiologic saline solution three 
times to remove the ethanol and then soaked in physio- 
logic saline solution for more than 20 minutes. 
Implantation of the conduit. Eight young mongrel dogs 
aged less than i year and weighing 7to 17 kg were used in 
this study. The left thoracic avity was entered though the 
fourth intercostal space with the dog under general anes- 
thesia with intravenous thiopental sodium (15 mg/kg) and 
mechanical ventilation. The pericardium was opened and 
the main pulmonary artery was exposed. Heparin was 
administered systemically (100 IU/kg). The initial dose of 
heparin was calculated at 100 units per kilogram of body 
weight. The right ventricular outflow tract was partially 
clamped longitudinally to prevent damage to the coronary 
artery, and a 3 cm incision was made. The proximal 
anastomosis was performed by a continuous over-and- 
over suture with 5-0 polypropylene. The main pulmonary 
artery was partially clamped longitudinally and incised for 
Fig. 1. Microscopic observation of the luminal surface of 
the prepared graft. The graft was composed of collagen 
fibers and elastic laminae. Arrowheads indicate leaflet. 
(Victoria blue staining; original magnification × 100.) 
about 2 cm. The distal anastomosis was done with 6-0 
polypropylene. After all air had been excluded from inside 
the graft, the clamps were released, and the main pulmo- 
nary artery was ligated at the site between the anastomosis 
and the pulmonary artery valve. Anticoagulant therapy 
was not used after the operation. 
All animal care was in compliance with the "Principles 
of Laboratory Animal Care" formulated by the National 
Society for Medical Research and the "Guide for the Care 
and Use of Laboratory Animals" prepared by the Na- 
tional Academy of Sciences and published bythe National 
Institutes of Health (NIH publication No. 80-23, revised 
1985). 
Cardiac catheterization study. A 7F thermodilution 
catheter was inserted through the l ft femoral vein under 
the same general anesthesia as described earlier. The right 
ventricular-pulmonary terial pressure gradient across 
the conduit was measured at 182 days in five dogs and at 
196, 376, and 386 days after the operation in the other 
three dogs. Cardiac catheterization, followed by angiog- 
raphy and echocardiography, was done just before the 
graft retrieval. 
Angiographic study. An angiographic catheter was in- 
serted through the same vessel to allow for catheteriza- 
tion. Conventional right ventricular angiography with cut 
film was recorded in three dogs at 182 days while about 30 
ml of contrast media was being manually injected into he 
right ventricle in the left anterior oblique position. Con- 
ventional pulmonary artery angiography with motion pic- 
ture film was also performed in two dogs at 182 and 375 
days, respectively, with the same procedure. 
Echocardiography. A left thoracotomy was performed 
through the fourth intercostal space with the animal under 
general anesthesia. Eehocardiography was conducted i- 
rectly on the graft in two dogs at 182 days and in two dogs 
at 196 and 385 days, respectively. 
Graft retrieval. All grafts were harvested from 182 days to 
385 days after the operation with the aid of general anesthe- 
sia. Five grafts were explanted at 182 days and three grafts at 
196, 375, and 385 days after the operation, respectively. 
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Fig. 2. The natural trileaflet valve of bovine jugular vein 
graft. Left, Systole: The leaflets opened softly. Center. 
Midsystole. Right, Diastole: The leaflets closed com- 
pletely. 
Before harvesting, sodium heparin (!00 IU/kg) was admin- 
istered intravenously m prevent dotting. All retrieved grafts 
were rinsed with saline solution to remove xcess intralumi- 
nal blood and were inspected macr0scopically. 
Observations. For light microscopic observation, 3 mm 
wide sections of the grafts were cut longitudinally from the 
right ventricular anastomosis to the pulmonary arterial 
anastomosis. Each sample was cut into four pieces, and 
identity marks were placed from the proximal to the distal 
area to observe the entire length of the graft in sequence. 
These specimens were fixed with 1% glutaraldehyde in 
phosphate buffered solution. 0.2 mol/L pH 7.4, and 
embedded ina hydrophilic resin (Technovite 7100; Kulzer 
& Co. GmbH, Germany). Sections were stained with 
hematoxylin and eosin, von Kossa stain for the detection 
of calcification. Papanicolaou's method for the detection 
of factor VIII of endothelial cells. Victoria blue for 
collagen, and van Gieson elastin for the detection of
elastic fiber. 
Results 
Prepared grafts. The bovine jugular vein grafts 
cross-linked with PC were soft and pliable like 
native venous tissue, that is. the grafts maintained 
their original mechanical properties. We could 
choose a suitable graft from various ones with an 
internal diameter of from 10 to 30 mm with two or 
three natural leaflets. The leaflets were also ex- 
tremely thin and soft. In saline solution, the leaflets 
could open and close with a minimum flow of saline 
solution (Fig. 2). In the present study, grafts of 18 to 
20 mm internal diameter with three leaflets were 
used. The outer surface of the graft was white and 
rough with connective tissue velour. The luminal 
surface was shiny and white (Fig. 3). The graft wall 
was tough enough to retain sutures. 
Implantation of the graft. The graft could be 
bent to arc on the right ventricular outflow tract 
because of its elasticity. Handling of the graft, 
suturability, and coaptation during anastomosis 
Fig. 3. The bovine jugular vein graft. The outer surface has 
rough collagen velour. 
were not much different from those of native blood 
vessels. During implantation, blood clotted on the 
outer surface, but no blood clots adhered to the 
luminal surface at all. After the clamps were re- 
leased, no bleeding occurred from the suture line or 
through the graft wall. After ligation of the original 
main pulmonary artery, all the blood flowed through 
the graft, but the right ventricle was not dilated. 
Opening and closing of the valve were detected by
palpation (Fig. 4). Neither kinking, hyperdilatation, 
nor collapse of the graft was observed. During and 
after implantation, o undesirable complication de- 
veloped in any of the animals. 
Catheter examination. The results of cardiac 
catheterization study are shown in Table I. The 
pressures in the pulmonary artery ranged from 18/9 
to 31/4 mm Hg and in the right ventricle from 18/4 
to 78/0 mm Hg. In one dog at 182 days after the 
operation (dog 1 in Table I), the gradient across the 
conduit was 53 mm Hg. We found segmented nar- 
rowing at the proximal anastomotic site. Except in 
dog 1, the pressure gradient across the conduit valve 
ranged from 0 to 14 mm Hg (Fig. 5). The results of 
two dogs (dogs 4 and 5) were excluded because the 
ligation of the mare pulmonary artery was found to 
be incomplete in the exp!anted grafts. 
Angiographic examination. Right ventricular an- 
giography showed that all the grafts were patent and 
had no kinking. The inner surfaces of the conduits 
were smooth and had no stenosis (Fig. 6). Pulmo- 
nary artery cineangiography showed smooth blood 
flow without regurgitation. No stenosis was detected 
in the conduits at the valve areas or at the proximal 
and distal anastomotic sites except at the proximal 
anastomotic site of dog 1. 
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Table I. Cardiac catheterization data 
Dog RV PA Pressure gradient 
No. POD (mm Hg) (ram Hg) (ram Hg) 
1 182 78/0 25/10 53 
2 182 18/4 18/9 0 
3 182 27/3 28/10 1 
6 196 40/0 31/4 9 
7 375 34/0 20/4 14 
8 385 23/2 19/7 4 
POD, Postoperative day; RV, right ventricle; PA, pulmonary artery. 
Echocardiographic examination. Echocardiog- 
raphy revealed that motion of the valve leaflets in 
each conduit was natural in the low-pressure pulmo- 
nary arterial system for a long period. The leaflets 
did not show thickening or high echoic lesions, 
which would indicate calcification of the valve (Fig. 
7). Blood flow did not regurgitate through the valve 
in any of the conduits, and none of the graft wails 
became dilated. 
Retrieved grafts from animals. All the grafts 
were patent, maintained extensibility, elasticity, and 
softness without hard calcified lesions, and had no 
dilatation at the time of their harvesting. The lumi- 
nal surfaces were extremely smooth, without degen- 
erative changes. No graft stenosis was observed as a 
result of intimal hyperplasia. The luminal surfaces 
from the anastomotic sites to the areas near the 
valves were white and glistening without thrombus 
deposition in all the grafts (Fig. 8). However, in dog 
1 we found scar formation in the right ventricular 
muscle at the anastomotic site, resulted in narrow- 
ing of the conduit at the proximal end. Small pieces 
of fresh thrombus were present on 16 of 24 cusps, 
and one cusp was slightly deformed at 182 days. 
Microscopic observations. The explanted graft 
maintained its own structure, elastic fibers, and 
collagen fibers (Fig. 9). There was no migration of 
giant cells, macrophages, or lymphocytes caused 
by foreign body reactions, and there were no 
degenerative changes and no calcification in the 
graft wall. The specimens of the graft with von 
Kossa staining showed no calcification (Fig. 10). 
Neointima formation with endothelium-like cell 
lining was observed on the luminal surface in all 
the conduits from the anastomotic sites to the 
areas near the valves (Fig. 11). These ceils were 
positive for factor VIII with Papanicolaou stain- 
ing, suggesting that they were endothelial cells. 
On the valves and the adjacent areas, however, no 
endothelial cells were present. Small fresh throm- 
bus adhered to some cusps without fibroblast 
Fig. 4. The right ventricular-pulmonary rterial (RV-P54) 
bypass with the new graft. The Outer wall of the valve is 
slightly ballooned. 
migration. In the valve with slight deformation m 
case 1. we observed fibrin deposition with eryth- 
rocytes and fibr0blast migration. At both proximal 
and distal anast0motic sites, no intimal hyperpla- 
sia was present. 
Discussion 
The grafts made of bovine jugular vein with 
natural venous valves maintained natural valve func- 
tion in a low-pressure area Of the pulmonary arterial 
system for an entire 1-year observation period. No 
significant dilated area was present in any of the 
retrieved conduits. This finding was consistent with a 
short-term right ventricular angiographic observa- 
tion in a preliminary study. 16 The pressure gradient 
across the conduit valve ranged from 0 to 14 mm Hg, 
which was a satisfactory value when compared with 
the mean gradient across the conduit (22.8 mm Hg) 
at completion of the operation with an extracardiac 
conduit in clinics, n In one dog (dog 1), scar forma- 
tion was noted in the right ventricular muscle at the 
anastomotic site. This finding was consistent with 
the results of the angiographic examination. The 
high pressure gradient in this case was considered to 
be caused by this scar formation. 
Although we did not use any anticoagulants after 
the graft implantation, thrombus adhesion at the 
leaflets was minimal, and these thrombi were ex- 
tremely fresh without organization. Therefore the 
thrombi could have been created during the cathe- 
terization just before the graft retrieval. Endotheli- 
alization of the graft Surface was also observed 
without intimal hyperplasia or degenerative changes 
such as calcification. All this evidence indicates that 
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Fig. 5. The pressure gradient across the conduit valve at 385 days after the operation. 
Fig. 6. Right ventriculogram 182 days after the operation. 
The conduit was patent, unkinked, and undilated. Arrow- 
heads indicate the conduit. 
the graft worked perfectly as a right ventricular- 
pulmonary arterial valved conduit for a long period 
of time and should be considered for clinical use. 
In the current experiment, no control conduit was 
adopted because no suitable standard conduit for 
clinical use was available. Therefore we will discuss 
our results with the results reported in various 
references. 1-13 Total surgical repair of congenital 
heart lesions with pulmonary arterial-right ventric- 
ular discontinuity was first accomplished with an 
aortic homograft in a patient with tetralogy of Fallot 
and pulmonary atresia. 17 Many kinds of conduits 
have been reported for right ventricular outflow 
tract reconstruction, but no conduits have main- 
tained functional valves without degenerative 
changes or calcification without anticoagulant ther- 
apy. 1-13 
Recently, success has been reported with cryopre- 
served allografts, is' 19 These grafts functioned for 
more than i0 years, which was a tremendous result 
compared with our 1-year experiment. Unfortu- 
nately, almost all showed valvular regurgitation. 
Selection of the size of the grafts was also discussed, 
and immunogenic problems as the pathogenesis of
valve allograft failure were also pointed out. There 
are limitations to homografts, such as ready avail- 
ability and size of the graft. On the other hand, we 
could choose from grafts with an internal diameter 
of from 10 to 30 mm. There were no limitations of 
availability and size of the graft in our bioprostheses. 
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Fig. 7. Echocardiograms of the graft 385 days after the operation. RV, Right ventricle; PA, pulmonary 
artery. Valvular swaying ismaintained satisfactorily. 
Biologic valves made of porcine aortic valves have 
been used and are expected to maintain their func- 
tion continuously. Their leaflets are, however, too 
rigid to work in the low-pressure system, because 
these grafts originate from aortic valves, not from 
pulmonary valves. It has been reported that the ratio 
of thickness of the media of the pulmonary trunk to 
that of the aorta was approximately 0.6, 2° that the 
amount of pulmonary elastic tissue per unit of 
medial surface area in a histologic section was only 
50% to 60% of that in the aorta, 2° and that the total 
calcium content per g am of tissue in the pulmonary 
media was on an average less than half of that in the 
aortic counterpart. 21 Early calcification and stenosis 
of glutaraldehyde-treated porcine valves in children 
have been observed, y' 13 
Another problem is the cross-linking method. The 
grafts previously reported have been cross-linked 
with glutaraldehyde, which makes biologic materials 
stiff and hydrophobic. 22'23 Cytotoxicity of residual 
glutaraldehyde r leased from the graft long after 
implantation can also induce another problem, for- 
eign body reaction. 24 Host cells cannot migrate onto 
the cytotoxic areaY Therefore no endothelial cell 
lining can be hoped for in the glutaraldehyde- 
treated grafts. 
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Fig. 8. The inner surface of the explanted graft 196 days 
after the operation. No intimal hyperplasia and no throm- 
bus is apparent on the luminal surface of the graft except 
for a small thrombus on the valve. 
Previously, cardiac wall substitute composed of 
collagen-coated ultrafine polyester mesh cross- 
linked by a hydrophilic polyepoxy compound 
(CUFP) or glutaraldehyde-treated equine pericar- 
dium was evaluated for right ventricular outflow 
tract implantation i  dogs. There was endotheliali- 
zation in the CUFP with fibroblasts and smooth 
muscle-like cells, but no endothelialization was seen 
in the glutaraldehyde-treated graft without fibro- 
blasts. 26 The glutaraldehyde treatment completely 
alters the original properties of the grafts. 
To overcome these problems, we used three spe- 
cial technologies for the new valved conduit. First, 
as the raw material for the graft with valves, we used 
the bovine jugular vein, which has natural valves 
with adequate shape, structure, function, and me- 
chanical properties to work in the low-pressure 
system without thrombus formation. These remark- 
able characteristics annot be created by any one or 
combination of the various synthetic materials by 
means of currently available technology. Today's 
technology has produced various successful medical 
devices, but as raw materials for artificial organs, 
natural tissues and organs have still attractive prop- 
erties both morphologically and functionally. The 
natural vein with venous valves is a typical case. If 
we can preserve these remarkable properties of 
natural tissues by some kind of chemical modifica- 
tion, we can produce ideal artificial organs in various 
fields. 
Second, we used PC instead of glutaraldehyde for 
chemical cross-linking. PC cross-linking has been 
used for small-diameter vascular prostheses of bio- 
Fig. 9. Microscopic observation of the luminal surface of
the graft 385 days after the operation. (Van Gieson elastin 
stain; original magnification × 100.) 
logic origin to preserve natural tissue elasticity and 
pliability.27, 3o PC contains ether bounds in its mol- 
ecule. The ether bound is a free joint, and it makes 
the cross-linked graft soft and flexible. PC also 
contains hydroxyl groups in its molecule, which give 
the materials hydrophilicity. On the other hand, 
glutaraldehyde contains a continuous five-carbon 
chain, which is rigid and hydrophobic, and makes 
the cross-linked materials stiff and hydrophobic. 
Another advantage of PC is its low cytotoxicity 
compared with that of glutaraldehyde, 2s and mate- 
rials cross-linked with PC do not show foreign body 
reaction after implantation. 29'31 Host cells can pro- 
liferate on the graft surface and migrate into the 
graft framework with the hydrophilicity and low 
cytotoxicity offered by PC. Consequently, PC cross- 
linking can provide a suitable environment for host 
cell migration, resulting in endothelial cell lining on 
the graft surface. Microscopic observation in the 
current study indicated that the endothelial cells 
migrated 1 to 2 cm away from the suture lines to 
near the leaflets, but no endothelialization was 
noted on the leaflets. Because ndothelial cell divi- 
sion is limited by cell aging, endothelial lining to 
cover the entire surface of the graft is difficult. 32' 33 
In the present experiment, he valves maintained 
their original mechanical properties after the PC 
cross-linking. 
In general, biologic materials that contain colla- 
gen are thrombogenic, because collagen molecules 
have many amino groups that are positively charged 
and can accumulate negatively charged plate- 
lets.34, 35 These amino groups, however, a e used for 
the cross-linking reaction, and carboxyl groups in 
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Fig. 10. Microscopic observation of the luminal surface of 
the graft 385 days after the operation. (y  Kossa staining; 
original magnification × 100.) 
the collagen molecules become relatively dominant. 
Therefore the materials become negatively charged 
and become less thrombogenic, 36 since platelets, 
which have a negative charge, show repulsion to- 
ward the same charge. Moreover, biologic materials 
cross-linked with PC become hydrophilic, because 
PC contains hydroxyl groups. In general, hydrophilic 
substances in wet conditions are surrounded with 
water, and water does not initiate either platelet 
aggregation or fibrin precipitation. Therefore, after 
cross-linking with PC, the biologic materials acquire 
nonthrombogenic properties. 
Third, we used a special heparinization method 
for powerful antithrombogenicity. Heparin was 
bound in the luminal surface of the graft in which 
protamine sulfate was impregnated in advance and 
bound covalently during the PC cross-linking. Pro- 
tamine can bind heparin ionically and release it 
slowly after implantation. During the heparin re- 
lease, fibrin cannot precipitate on the graft surface, 
but endothelial cells can migrate and proliferate on 
i t s  Therefore, after heparin is gone, endothelial 
cells can prevent hrombus formation on the graft 
surface. Even in small-diameter g afts, the graft 
maintained its patency with the heparinization tech- 
nology in the aorta-coronary b pass for the entire 
1-year observation period. 29' 31, 37 The antithrombo- 
genicity induced by the slow release of heparin 
proved to be effective in the pulmonary arterial 
system, and the graft worked perfectly without an- 
ticoagulant therapy. This is a great advantage when 
the graft is used in infants and young children in 
whom anticoagulant treatments cannot be used af- 
ter implantation. 
Fig. 11. Microscopic observation fthe luminal surface of 
the graft 182 days after the operation. The graft shows 
endothelium-like cells. (Hematoxylin and eosi  staining; 
original magnification × 100.) 
Another concern related to biologic materials for 
infants and young children is degenerative changes 
such as calcification. Collagen materials cross-linked 
with PC have proved to induce less calcification than 
those cross-linked with glutaraldehyde. In growing 
rats, the calcification rate of biologic valves cross- 
linked with PC was less than 1% compared with 
those cross-linked with glutaraldehyde. 38 Previous 
articles on PC-cross-linked aortic valves implanted 
in both the systemic and the pulmonary arterial 
systems did not report any calcification. 38 In the 
present experiments, we did not use growing ani- 
mals, but young dogs less than 1 year old, and the 
graft showed no calcification during the observation 
period. We can expect a similar result in human 
beings as well. 
Peeling of the neointima has been reported as a 
complication ofright ventricular-pulmonary arterial 
conduits.9, 12 Our hypothesis i that the peeling is 
caused structurally by intimal hyperplasia associated 
with poor anchoring of the neointima on the graft 
surface and biologically poor cell affinity of the 
neointima to the graft surface. Highly porous Da- 
cron fabric grafts do not show peeling. 39' 4o In high 
cell-affinity grafts such as PC-cross-linked biologic 
materials, neointimae on the graft surfaces are thin 
and biologically stable and do not become detached 
from the luminal surfaces. Our grafts had a thin 
neointima, lined with endothelial cells without inti- 
mal hyperplasia, which adhered stably to the graft. 
We believe that the probability of peeling in our 
grafts is very low. 
In summary, we believe that the success of our 
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graft is due to the combination of three tech- 
niques: (1) use of natural tissue as raw material, 
(2) improved cross-linking, and (3) heparinization 
for antithrombogenesis. The combination of these 
techniques is applicable not only in conduits, but 
also in various other implantable artificial organs 
in general. We are now continuing our experi- 
ments to make results with these grafts compara- 
ble with the allograft results obtained with 10-year 
observation. 
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